摘要
Objective To study the efficacy and safety of tirofiban on acute ST segment elevation myocardial infarction(STEMI)in patients who do not receive early reperfusion therapy.Methods A total of 153 STEMI patients without early reperfusion therapy were randomly distributed into tirofiban group(therapeutic group,n=78)and non-tirofi-